miR-224-5p has been primarily described as a hepatomiR, and its expression is elevated by the NFkB inflammatory pathway activated by TNF-alpha in Hepatocellular Carcinoma Cells [33]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.